Detalhe da pesquisa
1.
Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention.
Am Heart J
; 269: 118-130, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38109988
2.
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.
Am J Kidney Dis
; 81(3): 307-317.e1, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36208798
3.
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
Eur Heart J
; 43(37): 3528-3538, 2022 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35265981
4.
Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials.
J Intern Med
; 292(4): 557-574, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35585779
5.
Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease.
Am Heart J
; 251: 78-90, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35654163
6.
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.
Europace
; 23(11): 1722-1730, 2021 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34096584
7.
Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus.
Platelets
; 30(3): 348-355, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-29547014
8.
Increased platelet reactivity and platelet-leukocyte aggregation after elective coronary bypass surgery.
Platelets
; 30(8): 975-981, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30422037
9.
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
Stroke
; 49(9): 2122-2128, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30354995
10.
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
Europace
; 20(3): 420-428, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28177459
11.
Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis.
Br J Clin Pharmacol
; 83(3): 642-652, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27730670
12.
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs.
Eur J Clin Pharmacol
; 73(10): 1315-1322, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28664360
13.
Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.
Nephrol Dial Transplant
; 31(6): 944-52, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26394646
14.
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.
Eur J Clin Pharmacol
; 72(3): 329-38, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26613954
15.
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
Eur J Clin Invest
; 44(3): 276-84, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24720535
16.
Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.
Eur J Clin Pharmacol
; 70(12): 1477-85, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25219360
17.
Risk prediction in stable angina pectoris.
Eur J Clin Invest
; 43(2): 141-51, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23278283
18.
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma.
Eur J Clin Pharmacol
; 69(11): 1875-81, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23784008
19.
Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial.
Nephrol Dial Transplant
; 27(9): 3540-6, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22700717
20.
Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease.
J Am Heart Assoc
; 11(14): e025813, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35861825